{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:52:16Z","timestamp":1766400736364,"version":"3.33.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajoc.2024.102213","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T08:26:47Z","timestamp":1730881607000},"page":"102213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Abnormal visual cortex activity using functional magnetic resonance imaging in treatment resistant photophobia in Friedreich Ataxia"],"prefix":"10.1016","volume":"36","author":[{"given":"Araliya N.","family":"Gunawardene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Valdes-Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpen","family":"Ortug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-6155","authenticated-orcid":false,"given":"Anat","family":"Galor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajoc.2024.102213_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041815","article-title":"Future prospects of gene therapy for friedreich's ataxia","volume":"22","author":"Ocana-Santero","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102213_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bmb\/ldx034","article-title":"Friedreich's ataxia: clinical features, pathogenesis and management","volume":"124","author":"Cook","year":"2017","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ajoc.2024.102213_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104606","article-title":"Friedreich ataxia- pathogenesis and implications for therapies","volume":"132","author":"Delatycki","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ajoc.2024.102213_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.12215","article-title":"Prevalence gradients of Friedreich's ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge","volume":"126","author":"Vankan","year":"2013","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102213_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0887-8994(03)00004-3","article-title":"Friedreich's ataxia","volume":"28","author":"Alper","year":"2003","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102213_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s13023-022-02568-3","article-title":"Clinical management guidelines for Friedreich ataxia: best practice in rare diseases","volume":"17","author":"Corben","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102213_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0002-9394(14)71000-1","article-title":"Ophthalmologic findings in patients with ataxia","volume":"123","author":"Rabiah","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"Pt 4","key":"10.1016\/j.ajoc.2024.102213_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/brain\/awm323","article-title":"Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia","volume":"131","author":"Fahey","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102213_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"issue":"Pt 1","key":"10.1016\/j.ajoc.2024.102213_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/awn269","article-title":"Visual system involvement in patients with Friedreich's ataxia","volume":"132","author":"Fortuna","year":"2009","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102213_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/WNO.0000000000000068","article-title":"Optical coherence tomography and visual field findings in patients with Friedreich ataxia","volume":"34","author":"Dag","year":"2014","journal-title":"J Neuro Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102213_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/eye.2011.291","article-title":"Ophthalmic features of Friedreich ataxia","volume":"26","author":"Noval","year":"2012","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.ajoc.2024.102213_bib13","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s00415-013-6978-z","article-title":"Analysis of the visual system in Friedreich ataxia","volume":"260","author":"Seyer","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.ajoc.2024.102213_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3389\/fneur.2020.00716","article-title":"Botulinum neurotoxin for the treatment of neuropathic pain","volume":"11","author":"Egeo","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.ajoc.2024.102213_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1202341","article-title":"Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia","volume":"17","author":"Reyes","year":"2023","journal-title":"Front Neurosci"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102213_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","article-title":"Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses","volume":"33","author":"Chalmers","year":"2010","journal-title":"Contact Lens Anterior Eye"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102213_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102213_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ICL.0000000000000249","article-title":"Characteristics of ocular pain complaints in patients with idiopathic dry eye symptoms","volume":"43","author":"Kalangara","year":"2017","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102213_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajoc.2024.102213_bib20","article-title":"Periorbital botulinum toxin A improves photophobia and sensations of dryness in patients without migraine: case series of four patients","volume":"19","author":"Venkateswaran","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102213_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pain.2009.07.018","article-title":"An fMRI case report of photophobia: activation of the trigeminal nociceptive pathway","volume":"145","author":"Moulton","year":"2009","journal-title":"Pain"},{"issue":"Suppl 1","key":"10.1016\/j.ajoc.2024.102213_bib22","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102213_bib23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/nimg.2002.1132","article-title":"Improved optimization for the robust and accurate linear registration and motion correction of brain images","volume":"17","author":"Jenkinson","year":"2002","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102213_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hbm.10062","article-title":"Fast robust automated brain extraction. Article","volume":"17","author":"Smith","year":"2002","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102213_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","article-title":"A global optimisation method for robust affine registration of brain images","volume":"5","author":"Jenkinson","year":"2001","journal-title":"Med Image Anal"},{"year":"1993","author":"Bidichandani","series-title":"Friedreich Ataxia","key":"10.1016\/j.ajoc.2024.102213_bib26"},{"key":"10.1016\/j.ajoc.2024.102213_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2022.09.020","article-title":"Clinical neuroimaging of photophobia in individuals with chronic ocular surface pain","volume":"246","author":"Choudhury","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.ajoc.2024.102213_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jnc.12317","article-title":"Clinical features of Friedreich's ataxia: classical and atypical phenotypes","volume":"126","author":"Parkinson","year":"2013","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102213_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/nmt-2022-0011","article-title":"Friedreich ataxia: clinical features and new developments","volume":"12","author":"Keita","year":"2022","journal-title":"Neurodegener Dis Manag"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102213_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080708","article-title":"Neuro-ophthalmological findings in friedreich's ataxia","volume":"11","author":"Rojas","year":"2021","journal-title":"J Personalized Med"},{"issue":"10","key":"10.1016\/j.ajoc.2024.102213_bib31","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1526-4610.2011.02013.x","article-title":"Photoreactivity of the occipital cortex measured by functional magnetic resonance imaging-blood oxygenation level dependent in migraine patients and healthy volunteers: pathophysiological implications","volume":"51","author":"Martin","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.ajoc.2024.102213_bib32","article-title":"Functional MRI studies in friedreich's ataxia: a systematic review","volume":"12","author":"Vavla","year":"2021","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102213_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/01.STR.0000198807.31299.43","article-title":"Altered hemodynamics and regional cerebral blood flow in patients with hemodynamically significant stenoses","volume":"37","author":"Roc","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102213_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.neuroimage.2007.02.035","article-title":"Hemodynamic response function in patients with stroke-induced aphasia: implications for fMRI data analysis","volume":"36","author":"Bonakdarpour","year":"2007","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102213_bib35","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bjophthalmol-2018-312649","article-title":"Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections","volume":"103","author":"Diel","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102213_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/EB.S234073","article-title":"Exploring the link between dry eye and migraine: from eye to brain","volume":"13","author":"Baksh","year":"2021","journal-title":"Eye Brain"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102213_bib37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bjophthalmol-2020-316417","article-title":"Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway","volume":"105","author":"Diel","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102213_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxicon.2017.09.003","article-title":"An update on new and unique uses of botulinum toxin in movement disorders","volume":"147","author":"Jankovic","year":"2018","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102213_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13010058","article-title":"Botulinum toxin: an update on pharmacology and newer products in development","volume":"13","author":"Choudhury","year":"2021","journal-title":"Toxins"},{"issue":"9","key":"10.1016\/j.ajoc.2024.102213_bib40","first-page":"9","article-title":"Botulinum toxin for the treatment of neuropathic pain","author":"Park","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.ajoc.2024.102213_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tox.2013.02.006","article-title":"Botulinum toxins: mechanisms of action, antinociception and clinical applications","volume":"306","author":"Wheeler","year":"2013","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102213_bib42","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/toxins7083127","article-title":"Botulinum toxin for neuropathic pain: a review of the literature","volume":"7","author":"Oh","year":"2015","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102213_bib43","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.pain.2010.07.029","article-title":"Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis","volume":"151","author":"Gazerani","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ajoc.2024.102213_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.toxicon.2017.02.010","article-title":"Botulinum toxin type A reduces inflammatory hypernociception induced by arthritis in the temporomadibular joint of rats","volume":"129","author":"Lora","year":"2017","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102213_bib45","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","article-title":"Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation","volume":"101","author":"Lucioni","year":"2008","journal-title":"BJU Int"},{"issue":"20","key":"10.1016\/j.ajoc.2024.102213_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006919","article-title":"A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102213_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncpuro1124","article-title":"Drug Insight: biological effects of botulinum toxin A in the lower urinary tract","volume":"5","author":"Chancellor","year":"2008","journal-title":"Nat Clin Pract Urol"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102213_bib48","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/pm\/pnaa028","article-title":"CGRP plasma levels decrease in classical trigeminal neuralgia patients treated with botulinum toxin type A: a pilot study","volume":"21","author":"Zhang","year":"2020","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102213_bib49","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/j.pain.0000000000000119","article-title":"OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine","volume":"156","author":"Cernuda-Morollon","year":"2015","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102213_bib50","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ICU.0000000000000768","article-title":"Alternative therapies for dry eye disease","volume":"32","author":"Mittal","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102213_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3389\/fnins.2019.00497","article-title":"Implication of melanopsin and trigeminal neural pathways in blue light photosensitivity in vivo","volume":"13","author":"Marek","year":"2019","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102213_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/WNO.0b013e3182474548","article-title":"Shedding light on photophobia","volume":"32","author":"Digre","year":"2012","journal-title":"J Neuro Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102213_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainresrev.2010.05.005","article-title":"The cerebellum and pain: passive integrator or active participator?","volume":"65","author":"Moulton","year":"2010","journal-title":"Brain Res Rev"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102213_bib54","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.bja.2019.03.033","article-title":"The sensory and affective components of pain: are they differentially modifiable dimensions or inseparable aspects of a unitary experience? A systematic review","volume":"123","author":"Talbot","year":"2019","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102213_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpain.2004.11.001","article-title":"Human brain mechanisms of pain perception and regulation in health and disease","volume":"9","author":"Apkarian","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.ajoc.2024.102213_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuroscience.2013.04.053","article-title":"Posterior hypothalamic modulation of light-evoked trigeminal neural activity and lacrimation","volume":"246","author":"Katagiri","year":"2013","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102213_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nn.2475","article-title":"A neural mechanism for exacerbation of headache by light","volume":"13","author":"Noseda","year":"2010","journal-title":"Nat Neurosci"},{"issue":"7371","key":"10.1016\/j.ajoc.2024.102213_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature10567","article-title":"Melanopsin signalling in mammalian iris and retina","volume":"479","author":"Xue","year":"2011","journal-title":"Nature"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624002238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624002238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:39:45Z","timestamp":1737693585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624002238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":58,"alternative-id":["S2451993624002238"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102213","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal visual cortex activity using functional magnetic resonance imaging in treatment resistant photophobia in Friedreich Ataxia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102213"}}